LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Corrigendum to "Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy" [J Vet Cardiol 25 (2019 Oct) 41-51].

    Yang, V K / Rush, J E / Bhasin, S / Wagers, A J / Lee, R T

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

    2024  

    Language English
    Publishing date 2024-03-28
    Publishing country Netherlands
    Document type Published Erratum
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2024.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy

    Yang, V.K / Bhasin, S / Lee, R.T / Rush, J.E / Wagers, A.J

    Journal of veterinary cardiology. 2019 Oct., v. 25

    2019  

    Abstract: Growth differentiation factor (GDF) 11 has been shown to reduce cardiac hypertrophy in mice. Low levels of GDF-11 are associated with cardiac hypertrophy in humans. The authors hypothesized that plasma GDF-11 level is decreased in cats with hypertrophic ... ...

    Abstract Growth differentiation factor (GDF) 11 has been shown to reduce cardiac hypertrophy in mice. Low levels of GDF-11 are associated with cardiac hypertrophy in humans. The authors hypothesized that plasma GDF-11 level is decreased in cats with hypertrophic cardiomyopathy (HCM). Given the close homology between GDF-11 and myostatin/GDF-8, GDF-8 levels were also assessed.Thirty-seven client-owned cats were enrolled, including cats with normal cardiac structure (n = 16), cats with HCM or hypertrophic obstructive cardiomyopathy (HOCM; n = 14), and cats with HCM and congestive heart failure (CHF; n = 7).Plasma samples were analyzed for GDF-8 and GDF-11 using liquid chromatography tandem-mass spectrometry. Levels of GDF-8 and GDF-11 were compared between cats with normal cardiac structure, HCM or HOCM, and CHF.No differences in GDF-11 concentrations were found between cats with normal cardiac structure and cats with HCM/HOCM, with or without history of CHF. Decreased GDF-8 concentrations were detected in cats with CHF compared to cats with HCM/HOCM without history of CHF (p=0.031) and cats with normal cardiac structure (p=0.027). Growth differentiation factor 8 was higher in cats with HOCM compared to those with CHF (p=0.002). No statistical difference was noted in GDF-8 level as a function of age, weight, or body condition score.Plasma GDF-11 was not different between cats with HCM/HOCM and cats with normal cardiac structure regardless of age. Plasma GDF-8 was decreased in cats with CHF compared to cats with normal cardiac structure and cats with asymptomatic HCM/HOCM, suggesting a possible role in CHF development.
    Keywords body condition ; cardiomyopathy ; cats ; heart failure ; humans ; hypertrophy ; liquid chromatography ; mice ; myostatin ; tandem mass spectrometry
    Language English
    Dates of publication 2019-10
    Size p. 41-51.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2019.08.002
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.

    Yang, V K / Rush, J E / Bhasin, S / Wagers, A J / Lee, R T

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

    2019  Volume 25, Page(s) 41–51

    Abstract: Objectives: Growth differentiation factor (GDF) 11 has been shown to reduce cardiac hypertrophy in mice. Low levels of GDF-11 are associated with cardiac hypertrophy in humans. The authors hypothesized that plasma GDF-11 level is decreased in cats with ... ...

    Abstract Objectives: Growth differentiation factor (GDF) 11 has been shown to reduce cardiac hypertrophy in mice. Low levels of GDF-11 are associated with cardiac hypertrophy in humans. The authors hypothesized that plasma GDF-11 level is decreased in cats with hypertrophic cardiomyopathy (HCM). Given the close homology between GDF-11 and myostatin/GDF-8, GDF-8 levels were also assessed.
    Animals: Thirty-seven client-owned cats were enrolled, including cats with normal cardiac structure (n = 16), cats with HCM or hypertrophic obstructive cardiomyopathy (HOCM; n = 14), and cats with HCM and congestive heart failure (CHF; n = 7).
    Methods: Plasma samples were analyzed for GDF-8 and GDF-11 using liquid chromatography tandem-mass spectrometry. Levels of GDF-8 and GDF-11 were compared between cats with normal cardiac structure, HCM or HOCM, and CHF.
    Results: No differences in GDF-11 concentrations were found between cats with normal cardiac structure and cats with HCM/HOCM, with or without history of CHF. Decreased GDF-8 concentrations were detected in cats with CHF compared to cats with HCM/HOCM without history of CHF (p=0.031) and cats with normal cardiac structure (p=0.027). Growth differentiation factor 8 was higher in cats with HOCM compared to those with CHF (p=0.002). No statistical difference was noted in GDF-8 level as a function of age, weight, or body condition score.
    Conclusions: Plasma GDF-11 was not different between cats with HCM/HOCM and cats with normal cardiac structure regardless of age. Plasma GDF-8 was decreased in cats with CHF compared to cats with normal cardiac structure and cats with asymptomatic HCM/HOCM, suggesting a possible role in CHF development.
    MeSH term(s) Animals ; Cardiomyopathy, Hypertrophic/blood ; Cardiomyopathy, Hypertrophic/complications ; Cardiomyopathy, Hypertrophic/veterinary ; Cat Diseases/blood ; Cats ; Female ; Growth Differentiation Factors/blood ; Heart Failure/blood ; Heart Failure/etiology ; Heart Failure/veterinary ; Male ; Myostatin/blood
    Chemical Substances Growth Differentiation Factors ; Myostatin
    Language English
    Publishing date 2019-09-01
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2019.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Extracardiac intrapericardial myxosarcoma causing right ventricular outflow tract obstruction in a dog.

    Karlin, E T / Yang, V K / Prabhakar, M / Gregorich, S L / Hahn, S / Rush, J E

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

    2018  Volume 20, Issue 2, Page(s) 129–135

    Abstract: A 13-year-old male castrated pomeranian cross was referred for evaluation of episodes of collapse and a suspected cardiac mass. The presence of a mass at the base of the heart within the pericardial space was confirmed by echocardiography. Additional ... ...

    Abstract A 13-year-old male castrated pomeranian cross was referred for evaluation of episodes of collapse and a suspected cardiac mass. The presence of a mass at the base of the heart within the pericardial space was confirmed by echocardiography. Additional diagnostics included computed tomography, ultrasound-guided fine-needle aspirate, and thoracic radiographs. The mass was surgically debulked and diagnosed as myxosarcoma via histopathology. This case report describes the diagnostic imaging, laboratory findings, and short-term positive clinical outcome of a dog with a myxosarcoma in a previously undescribed location.
    MeSH term(s) Animals ; Biopsy, Fine-Needle/veterinary ; Dog Diseases/diagnostic imaging ; Dog Diseases/surgery ; Dogs ; Echocardiography/veterinary ; Heart Neoplasms/diagnostic imaging ; Heart Neoplasms/surgery ; Heart Neoplasms/veterinary ; Male ; Myxosarcoma/diagnostic imaging ; Myxosarcoma/surgery ; Myxosarcoma/veterinary ; Pericardium ; Ventricular Outflow Obstruction/diagnostic imaging ; Ventricular Outflow Obstruction/veterinary
    Language English
    Publishing date 2018-03-01
    Publishing country Netherlands
    Document type Case Reports ; Journal Article
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2018.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.

    Pierce, K V / Rush, J E / Freeman, L M / Cunningham, S M / Yang, V K

    Journal of veterinary internal medicine

    2017  Volume 31, Issue 3, Page(s) 678–684

    Abstract: Background: Reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations after treatment have been associated with improved survival in people with congestive heart failure (CHF), but have not been reported in cats with CHF.: ... ...

    Abstract Background: Reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations after treatment have been associated with improved survival in people with congestive heart failure (CHF), but have not been reported in cats with CHF.
    Objectives: To evaluate changes in NT-proBNP concentrations in cats with CHF after treatment and determine whether serial NT-proBNP measurements provide prognostic information.
    Animals: Thirty-one client-owned cats.
    Methods: Prospective, observational study in cats with new onset CHF secondary to cardiomyopathy. Concentrations of NT-proBNP were measured within 4 hours of admission to the hospital, on the day of discharge, and at re-evaluation 7-10 days later.
    Results: Median NT-proBNP concentrations decreased significantly from admission (1,713 pmol/L [range, 160-3,784 pmol/L]) to discharge (902 pmol/L [range, 147-3,223 pmol/L]); P = .005) and from admission to re-evaluation (1,124 pmol/L [range, 111-2,727 pmol/L]; P = .024). Median survival time was 109 days (range, 1-709 days), with 5 cats still alive at the time of analysis. Cats with a larger percent decrease in NT-proBNP from admission to discharge had a longer survival time (P = .048). Cats with evidence of active CHF at the time of re-evaluation (P = .010) and cats whose owners had difficulty administering medications (P = .045) had shorter survival times.
    Conclusions and clinical importance: Cats with a larger percent decrease in NT-proBNP during hospitalization and no evidence of CHF at the time of re-evaluation had longer survival times. Additional studies are needed to determine whether NT-proBNP can help guide treatment in cats with CHF.
    MeSH term(s) Animals ; Biomarkers/blood ; Cat Diseases/blood ; Cat Diseases/mortality ; Cats ; Female ; Heart Failure/mortality ; Heart Failure/veterinary ; Male ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prospective Studies ; Severity of Illness Index ; Survival Analysis
    Chemical Substances Biomarkers ; Peptide Fragments ; pro-brain natriuretic peptide (1-76) ; Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2017-05
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 92798-3
    ISSN 1939-1676 ; 0891-6640
    ISSN (online) 1939-1676
    ISSN 0891-6640
    DOI 10.1111/jvim.14690
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Dilated cardiomyopathy in cats: survey of veterinary cardiologists and retrospective evaluation of a possible association with diet

    Karp, S.I. / Freeman, L.M. / Rush, J.E. / Arsenault, W.G. / Cunningham, S.M. / DeFrancesco, T.C. / Karlin, E.T. / Laste, N.J. / Lefbom, B.K. / Plante, C. / Rodriguez, K.T. / Tyrrell, W.D. / Yang, V.K.

    Journal of veterinary cardiology. 2022 Feb., v. 39

    2022  

    Abstract: The objectives were to conduct a survey of cardiologists on their recent experiences with cats that have dilated cardiomyopathy (DCM) and to retrospectively review individual cases of feline DCM. Part one: A survey was distributed to cardiologists with ... ...

    Abstract The objectives were to conduct a survey of cardiologists on their recent experiences with cats that have dilated cardiomyopathy (DCM) and to retrospectively review individual cases of feline DCM. Part one: A survey was distributed to cardiologists with questions regarding caseload and clinical management of cats with DCM diagnosed over the past two years. Part two: Cardiologists completing the survey were invited to submit data from cats recently diagnosed with DCM. Data on signalment, clinical signs, diet, echocardiographic measurements and outcome were recorded. Part one: From 52 completed surveys, many cardiologists responded that measuring and supplementing taurine and recommending a diet change in cats with DCM are common practices. Few (15%) cardiologists reported an increase in the number of feline DCM cases over the past two years, although some had cases that improved even if taurine deficiency was not present. Part two: Twenty of 37 (54%) cats ate low pea/lentil (low PL) diets, and 14/37 (38%) ate high PL diets at the time of diagnosis; three had incomplete diet information. Two of 13 cats (15%) in which taurine was measured had levels below the reference range. After adjusting for other variables, cats eating high PL diets that changed diets after diagnosis had a significantly longer survival time than that of cats eating high PL diets that did not change diets after diagnosis (P = 0.025). Additional research is warranted to determine whether there could be a possible association between diet and DCM in cats.
    Keywords cardiomyopathy ; cats ; diet ; echocardiography ; lentils ; nutrition information ; peas ; retrospective studies ; surveys ; taurine
    Language English
    Dates of publication 2022-02
    Size p. 22-34.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2021.11.002
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Dilated cardiomyopathy in cats: survey of veterinary cardiologists and retrospective evaluation of a possible association with diet.

    Karp, S I / Freeman, L M / Rush, J E / Arsenault, W G / Cunningham, S M / DeFrancesco, T C / Karlin, E T / Laste, N J / Lefbom, B K / Plante, C / Rodriguez, K T / Tyrrell, W D / Yang, V K

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

    2021  Volume 39, Page(s) 22–34

    Abstract: Introduction/objectives: The objectives were to conduct a survey of cardiologists on their recent experiences with cats that have dilated cardiomyopathy (DCM) and to retrospectively review individual cases of feline DCM.: Animals, materials and ... ...

    Abstract Introduction/objectives: The objectives were to conduct a survey of cardiologists on their recent experiences with cats that have dilated cardiomyopathy (DCM) and to retrospectively review individual cases of feline DCM.
    Animals, materials and methods: Part one: A survey was distributed to cardiologists with questions regarding caseload and clinical management of cats with DCM diagnosed over the past two years. Part two: Cardiologists completing the survey were invited to submit data from cats recently diagnosed with DCM. Data on signalment, clinical signs, diet, echocardiographic measurements and outcome were recorded.
    Results: Part one: From 52 completed surveys, many cardiologists responded that measuring and supplementing taurine and recommending a diet change in cats with DCM are common practices. Few (15%) cardiologists reported an increase in the number of feline DCM cases over the past two years, although some had cases that improved even if taurine deficiency was not present. Part two: Twenty of 37 (54%) cats ate low pea/lentil (low PL) diets, and 14/37 (38%) ate high PL diets at the time of diagnosis; three had incomplete diet information. Two of 13 cats (15%) in which taurine was measured had levels below the reference range. After adjusting for other variables, cats eating high PL diets that changed diets after diagnosis had a significantly longer survival time than that of cats eating high PL diets that did not change diets after diagnosis (P = 0.025).
    Conclusions: Additional research is warranted to determine whether there could be a possible association between diet and DCM in cats.
    MeSH term(s) Animals ; Cardiologists ; Cardiomyopathy, Dilated/veterinary ; Cat Diseases/epidemiology ; Cat Diseases/etiology ; Cats ; Diet/veterinary ; Dogs ; Humans ; Retrospective Studies
    Language English
    Publishing date 2021-11-20
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2198278-8
    ISSN 1875-0834 ; 1760-2734
    ISSN (online) 1875-0834
    ISSN 1760-2734
    DOI 10.1016/j.jvc.2021.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy

    Yang, V.K / Freeman, L.M / Rush, J.E

    American journal of veterinary research. 2008 Aug., v. 69, no. 8

    2008  

    Keywords cats ; cat diseases ; cardiomyopathy ; pathogenesis ; risk factors ; abnormal development ; hypertrophy ; insulin-like growth factor I ; normal values ; morphometry ; body size ; skeleton ; heart ; blood chemistry ; blood serum ; disease diagnosis ; biomarkers
    Language English
    Dates of publication 2008-08
    Size p. 1061-1066.
    Document type Article
    ZDB-ID 390796-x
    ISSN 1943-5681 ; 0002-9645
    ISSN (online) 1943-5681
    ISSN 0002-9645
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top